Empirical optimization of dual-sgRNA design for in vivo CRISPR/Cas9-mediated exon deletion in mice
Computational and Structural Biotechnology Journal · 2026-01 · 31 · 355-362
DOI: 10.1016/j.csbj.2026.01.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 10.01.2026. Verfasst von Sung-Yeon Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: GEM Division, Macrogen Inc., Seoul, Republic of Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
CRISPR/Cas9 has transformed gene editing, enabling precise genetic modifications across species. However, existing sgRNA design prediction models based on in vitro data are difficult to generalize to in vivo contexts. In particular, approaches based on single-sgRNA design require additional filtering of in-frame mutations, which is inefficient in terms of both time and cost. In this study, we developed the first mammalian in vivo-trained prediction model to evaluate the efficiency of a dual-sgRNA-based exon deletion strategy. Using 230 editing outcomes of postnatal viable individuals, eight prediction models were constructed and evaluated based on generalized linear models and Random Forests. The final selected model, a Combined GLM, integrated the DeepSpCas9 score with k-mer sequence features, achieving an AUC of 0.759 (95 % Confidence Interval: 0.697-0.821). Motif analysis revealed that CC sequences were associated with high efficiency and TT sequences were associated with low editing efficiency. This study demonstrates that integrating sequence-based features with existing design scores can improve sgRNA efficiency prediction in vivo. The proposed framework can be applied to the development of next-generation sgRNA design tools, with implications for gene therapy, effective animal model generation, and precision genome engineering.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GEM Division, Macrogen Inc., Seoul, Republic of Korea.
Zitieren
APA
Lee, S. Y., Ma, S., Jeon, S. D., Kim, H., Jo, B., Han, S. H., Jang, E., Lee, J., Lee, Y. K., & Lee, D. (2026). Empirical optimization of dual-sgRNA design for in vivo CRISPR/Cas9-mediated exon deletion in mice. Computational and Structural Biotechnology Journal, 31, 355-362. https://doi.org/10.1016/j.csbj.2026.01.002
Vancouver
Lee SY, Ma S, Jeon SD, Kim H, Jo B, Han SH, et al. Empirical optimization of dual-sgRNA design for in vivo CRISPR/Cas9-mediated exon deletion in mice. Computational and Structural Biotechnology Journal. 2026;31:355-362. doi:10.1016/j.csbj.2026.01.002
BibTeX
@article{Lee2026,
author = {Lee, Sung-Yeon and Ma, Seongwon and Jeon, Sangjun Davie and Kim, Hyoju and Jo, Beomjoon and Han, Seung-Hoon and Jang, Eunsoo and Lee, Jimin and Lee, Yong-Kyu and Lee, Dasom},
title = {Empirical optimization of dual-sgRNA design for in vivo CRISPR/Cas9-mediated exon deletion in mice},
journal = {Computational and Structural Biotechnology Journal},
year = {2026},
volume = {31},
pages = {355--362},
doi = {10.1016/j.csbj.2026.01.002}
}
EUVIMED